CU6 5.15% $4.60 clarity pharmaceuticals ltd

Research/Valuation, page-275

  1. 2,598 Posts.
    lightbulb Created with Sketch. 2723
    generally you partner early for cash, development expertise and foot in the door for M&A. Cash and development is under control and pipeline is advanced in a hot sector. Can see this being one and done, by way of a trading halt for deal in 2025 - but who really knows?
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.